Clinical Trial Update: Lactobacillus LB as Treatment for Irritable Bowel Syndrome With Predominance of Diarrhea (IBS-D) [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating Lactobacillus LB for Irritable Bowel Syndrome with Diarrhea (IBS-D).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome with Diarrhea

Drugs mentioned

• Lactobacillus LB

Snippet

Sponsor: Hospital General de Mexico | Conditions: Irritable Bowel Syndrome With Diarrhea | Phase 4 | Status: COMPLETED